Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified vs Conventional SAP Block for VATS
NCT05661253Unknown
- Sponsor
- Zagazig University
- Start
- Dec 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine in acute postoperative pain, sponsored by Zagazig University. Primary endpoint: Tramadol consumption at 24 hours. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on NCT05661253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05661253.